Mitochondrial dysfunction: Understanding how dysfunctional mitochondrial redox metabolism underpins pathology

Mitochondria—the tiny power plants inside nearly every human cell—are failing in ways scientists do not fully understand, and this group is building the tools to find out why. The problem is that when mitochondria malfunction, they disrupt the cell’s redox balance: the careful chemical dance of reactive oxygen species and other molecules that can either signal the cell to behave normally or push it toward disease. Researchers know this breakdown contributes to conditions such as diabetes, neurodegeneration, and muscle disorders, but they lack the precise instruments to watch it happen in living tissue. This group aims to close that gap. To do so, they are designing new chemical probes that can report on mitochondrial redox activity inside living organisms, and developing bioactive molecules that can manipulate that activity on demand. If successful, these tools will let scientists see exactly when and how mitochondrial dysfunction drives pathology—and identify new drug targets to stop it. This is fundamental science. It will not produce a therapy next year. But without this kind of mechanistic understanding, efforts to treat mitochondrial disease remain shots in the dark.